Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
This study has been completed.
Study NCT00006398 Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: October 5, 2000 Last Updated: May 4, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophageal and Gastric Varices
Liver Cirrhosis
Portal Hypertension
Additional conditions recognized in this trial
Esophageal Diseases
Fibrosis
Hypertension
Hypertension, Portal
Varicose Veins
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Gastrointestinal Diseases
Liver Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Timolol Maleate
Additional drug interventions recognized in this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Timolol
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
